Drug design and development company Isomorphic Labs announced it raised $600 million in its first external funding round.
Thrive Capital led the round, with participation from GV (Google Ventures) and existing investor Alphabet.
WHAT IT DOES
Isomorphic Labs, launched in 2021 with Google DeepMind, unveiled its newest joint AI offering AlphaFold 3, an AI model that was developed by Isomorphic Labs...
Workforce management technology company Hallmark announced a strategic integration with CareRev, an on-demand workforce platform for acute care.
The joint alliance aims to give Hallmark customers instant access to CareRev's network of 35,000-plus qualified per diem nurses.
CareRev provides access to a flexible workforce by allowing nurse managers to pull from a pool of experienced clinicians who...
Employee health benefits management platform Collective Health is partnering with digital healthcare platform and weight loss company Noom's enterprise division, Noom Health, to deliver Collective Health + Noom Med with SmartRx, an enterprise weight management platform with an integrated GLP-1 drug program that will be accessible to Collective Health employer customers.
The partnership will...
Infusion and chronic care management company Uptiv Health announced a partnership with the automation platform Lamar Health to implement AI-powered automation for referral intake and prior authorization processes.
Uptiv offers infusion therapy for patients with chronic conditions via a hybrid model that merges customized in-clinic care with a digital platform.
In addition to traditional infusion...
Health technology company Royal Philips has expanded its partnership with Ibex Medical Analytics that includes a new release of the Philips IntelliSite Pathology Solution (PIPS) to speed up adoption of AI-enabled digital pathology tools.
In 2021, Philips and Ibex combined PIPS with Ibex’s Galen AI-powered cancer diagnostics platform.
The agreement then was aimed at helping pathologists generate...
Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable.
Nanowear offers home-based, AI-enabled digital diagnostics for cardiometabolic health. The company's FDA-cleared SimpleSense wearable reads patient vitals, such...
Aura, an AI-enabled digital protection platform, announced it officially closed its Series G funding round, raising $140 million in equity and debt and bringing its valuation to $1.6 billion. The round initially closed in August 2024.
Ten Eleven Ventures and Madrone Capital led the round, with participation from new investor AT&T Ventures. Existing investors General Catalyst, Warburg Pincus...
Amboss, a medical education company for medical students and healthcare stakeholders, closed a €240 million ($259.44 million) financing round.
The round included new primary investors KIRKBI, M&G Investments and Lightrock, with participation from existing shareholders. The company recently converted to a European stock corporation (SE).
WHAT IT DOES
Amboss helps medical students and...
Evinova, a clinical trial technology company, is partnering with Quantum Leap Healthcare Collaborative (QLHC) to integrate Evinova’s remote patient monitoring (RPM) offering into I-SPY 2.2, a platform trial that provides a framework to study multiple novel therapeutic treatment arms for women with newly diagnosed, locally advanced breast cancer.
A platform trial is a clinical trial design that...
Human genetics and biotechnology company 23andMe has filed for Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri to facilitate a sales process.
In a press release, the company said it intends to continue operating its business throughout the sales process and no changes will be made to the way the company will store, manage or protect customer data.
Anne...
